Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer

Masayuki Shirasawa^{1

2

3}, Tatsuya Yoshida^{4

5}, Kouya Shiraishi², Naoko Goto¹, Shigehiro Yagishita⁶, Tatsuya Imabayashi⁷, Yuji Matsumoto^{1

7}, Ken Masuda¹, Yuki Shinno¹, Yusuke Okuma¹, Yasushi Goto¹, Hidehito Horinouchi¹, Masaya Yotsukura⁸, Yukihiro Yoshida⁸, Kazuo Nakagawa⁸, Katsuhiko Naoki³, Takaaki Tsuchida⁷, Ryuji Hamamoto⁹, Noboru Yamamoto^{1

6}, Noriko Motoi^{2

10

11}, Takashi Kohno², Shun-Ichi Watanabe⁸, Yuichiro Ohe¹

Affiliations

¹ Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
² Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
³ Department of Respiratory Medicine, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ku, Sagamihara city, Kanagawa, 252-0375, Japan.
⁴ Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tatyoshi@ncc.go.jp.
⁵ Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tatyoshi@ncc.go.jp.
⁶ Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
⁷ Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
⁸ Department of Thoracic Surgery, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
⁹ Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
¹⁰ Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
¹¹ Department of Pathology, Saitama Cancer Center, Saitama, 362-0806, Japan.

Published Erratum

Masayuki Shirasawa et al. Br J Cancer. 2023 Dec.

. 2023 Dec;129(12):2034.

doi: 10.1038/s41416-023-02481-x.

¹ Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
² Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
³ Department of Respiratory Medicine, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ku, Sagamihara city, Kanagawa, 252-0375, Japan.
⁴ Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tatyoshi@ncc.go.jp.
⁵ Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tatyoshi@ncc.go.jp.
⁶ Division of Molecular Pharmacology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
⁷ Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
⁸ Department of Thoracic Surgery, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
⁹ Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
¹⁰ Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
¹¹ Department of Pathology, Saitama Cancer Center, Saitama, 362-0806, Japan.

No abstract available

Erratum for

Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Naoki K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Shirasawa M, et al. Br J Cancer. 2023 Dec;129(12):2003-2013. doi: 10.1038/s41416-023-02427-3. Epub 2023 Sep 20. Br J Cancer. 2023. PMID: 37731022 Free PMC article.